Imricor Medical Systems (ASX:IMR) said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.
The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.
Imricor Medical Systems shares rose past 2% in morning trade Thursday.
Price (AUD): $1.66, Change: $+0.040, Percent Change: +2.47%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。